No Medical Value? US Govt has been Funding this Israeli Cannabis Researcher for 50 Years
As many Americans approach November 4 with a sense of dread, facing the fact that either Donald Trump or Hillary Clinton will be the next president, much more hopeful things will be going on that day. Residents in at least nine states will be voting on ballot initiatives to legalize recreational or medical cannabis use.
Considering the tide of public opinion in favor of legalization, we can expect that most, if not all, of these states will vote for freedom and access to a wondrous medicinal plant. Even the power of Big Pharma, which is pouring money into campaigns to derail legalization efforts since medical cannabis threatens their profits, might be no match for the mass awakening.
For the most part it’s up to the states to lead the way, since federal government appears to be firmly stuck in prohibition. The DEA, which preys on the populace through the drug war, just reaffirmed its commitment to lunacy by keeping cannabis as a Schedule 1 drug with “no currently accepted medical use.” This policy, having no basis in reality, guides the federal government’s attitude.
We could go on about the mountains of scientific evidence that have come out on the medical benefits of cannabis and its extracts, or the fact that the American Epilepsy Society considers CBD oil to have the greatest potential for treating epileptic seizures, or the fact that many veterans with PTSD find cannabis to be the only effective treatment, and so on.
While the feds were throwing people in cages for weed possession in its escalation of the war on drugs — based on false pretenses, racism and suppression of the antiwar movement — another part of the government was funding medical cannabis research the entire time.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1470694951173-5'); });
//tags-cdn.deployads.com/a/activistpost.com.js
(deployads = window.deployads || ).push({});